Notice of Dividend

RNS Number : 3601U

Assura PLC

02 December 2021

 

2 December 2021

Assura plc

Notice of Dividend

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.74 pence per share will be paid on 12 January 2022 to shareholders on the register on 10 December 2021 (the "Record Date"). The Ex-dividend Date will be 9 December 2021.

This interim dividend will be a normal dividend (non-PID). Please refer to Company's website HERE for more information .

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 16 December 2021.

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 29 December 2021 either to return their completed mandate form to the Company registrars, Link Group at 10^th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

The Circular concerning this Scrip Dividend Alternative is available on the Company's website,  www.assuraplc.com and is also available for inspection at the National Storage Mechanism  https://data.fca.org.uk/#/nsm/nationalstoragemechanism .  

- Ends -

For more information, please contact:

Assura plc	Tel: [phone]
Orla Ball, Company Secretary David Purcell, Head of Investor Relations	Email: [e-mail]
Finsbury Gordon Simpson James Thompson	Tel: [phone] Email: [e-mail]

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at 2,595 million.

Further information is available at www.assuraplc.com

* EPRA is a registered trademark of the European Public Real Estate Association  

 

END

 

 

DIVUPGAAPUPGURP